ArthroCare Restatement Will Cut Up To $37 Million From ’06-’08 Sales Reports
This article was originally published in The Gray Sheet
Executive Summary
Radiofrequency surgical instrument maker ArthroCare plans to restate previously filed financial statements from 2006-2008 to account for improper recording of sales to certain entities, resulting in a $26 million-$37 million reduction in previously recorded revenues
You may also be interested in...
ArthroCare CEO Resigns As Inquiry Into Accounting, Billing Practices Expands
Veteran health care exec and ArthroCare board member David Fitzgerald will step in as acting CEO of the embattled surgical instrument maker now that former chief exec Michael Baker has resigned in the shadow of an accounting scandal and government investigations
ArthroCare CEO Resigns As Inquiry Into Accounting, Billing Practices Expands
Veteran health care exec and ArthroCare board member David Fitzgerald will step in as acting CEO of the embattled surgical instrument maker now that former chief exec Michael Baker has resigned in the shadow of an accounting scandal and government investigations
ArthroCare Expands Accounting Inquiry To All Divisions Dating Back To 2000
Troubled surgical instrument maker ArthroCare will expand the scope of a previously planned restatement of financial results to encompass all three of its business units for the past eight years to account for improper recording of sales to certain entities